3692:HKG
Hansoh Pharmaceutical Group Company Ltd
HK$ 31.74
arrow_upward
+1.15%(+0.36) Siku 1
16 Okt, 16:08:14 GMT +8 · HKD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 3692...
Fungua
HK$ 31.72
Juu
HK$ 32.44
Chini
HK$ 31.52
Mtaji wa soko
192.48B
Wastani wa kiasi cha mauzo
8.58M
Kiasi cha mauzo ya hisa
10.50M
Gawio
1.53%
Mgawo wa faida wa kila robo mwaka
HK$ 0.12
Tarehe ya kutojumuisha gawio
22 Sep 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
24.51
Juu kwa wiki 52
HK$ 44.22
Chini kwa wiki 52
HK$ 28.06
EPS
HK$ 1.30
Idadi ya wafanyakazi
elfu 10
Fungua
HK$ 31.72
Juu
HK$ 32.44
Chini
HK$ 31.52
Mtaji wa soko
192.48B
Wastani wa kiasi cha mauzo
8.58M
Kiasi cha mauzo ya hisa
10.50M
Gawio
1.53%
Mgawo wa faida wa kila robo mwaka
HK$ 0.12
Tarehe ya kutojumuisha gawio
22 Sep 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
24.51
Juu kwa wiki 52
HK$ 44.22
Chini kwa wiki 52
HK$ 28.06
EPS
HK$ 1.30
Idadi ya wafanyakazi
elfu 10
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 18 zilizopita
Hansoh Pharma stock gets HKD 47.82 consensus target
Simply Wall Street
·
saa 18 zilizopita
Could EMA Review Alter The Investment Case For Hansoh Pharma Stock (SEHK:3692)?
Wasifu
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Kuhusu Hansoh Pharmaceutical Group Company Ltd